Nalaganje...
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
T cells genetically engineered to express chimeric antigen receptors (CARs) have proven — and impressive — therapeutic activity in patients with certain subtypes of B cell leukaemia or lymphoma, with promising efficacy also demonstrated in patients with multiple myeloma. Nevertheless, various barrie...
Shranjeno v:
| izdano v: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7223338/ https://ncbi.nlm.nih.gov/pubmed/31848460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41571-019-0297-y |
| Oznake: |
Označite
Brez oznak, prvi označite!
|